BGAI
AMED

Bruce G. Allen Investments’s Amedisys AMED Stock Holding History

Bruce G. Allen Investments’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7
Closed -$689 – 1082
2025
Q2 		$689 Buy
7
+5
+250% +$473 ﹤0.01% 898
2025
Q1 		$185 Hold
2
– – ﹤0.01% 1060
2024
Q4 		$182 Hold
2
– – ﹤0.01% 1069
2024
Q3 		$193 Hold
2
– – ﹤0.01% 1088
2024
Q2 		$184 Sell
2
-7
-78% -$650 ﹤0.01% 961
2024
Q1 		$829 Buy
9
+7
+350% +$656 ﹤0.01% 803
2023
Q4 		$190 Buy
+2
New +$187 ﹤0.01% 994

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bruce G. Allen Investments's AMED Position: Q3 2025 in Review

Bruce G. Allen Investments sold out of Amedisys (AMED) in Q3 2025, closing a stake of 7 shares — an estimated $689 sold.

Bruce G. Allen Investments first reported a position in AMED in Q4 2023 and held it in 7 quarters. The position peaked at $829 in Q1 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Bruce G. Allen Investments reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Bruce G. Allen Investments sold 7 Amedisys shares in Q3 2025, an estimated $689.
  • Bruce G. Allen Investments first reported a position in Amedisys in Q4 2023 and held it in 7 quarters.
  • Bruce G. Allen Investments's Amedisys position peaked at $829 in Q1 2024.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Bruce G. Allen Investments's 13F filing for Q3 2025, filed 30 Oct 2025.